HOTH News and Press, Hoth Therapeutics Inc. From 10/11/19

Spherix Incorporated (NASDAQ: SPEX ) approved  (Oct. 2, 2019) a distribution to Spherix stockholders of 0.1M shares of Hoth Therapeutics (NASDAQ: HOTH ) held by Spherix. Spherix stockholder will receive one share of Hoth common stock for every twenty-nine shares of Spherix common sto...

NEW YORK , Oct. 8, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chr...

NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Wall Street Reporter will be hosting the “NEXT SUPER STOCK - Live !” livestream online-only investor conference on Thursday September 26, 2019 from 12:00PM-1:00PM EST. Registration is free. Click here to join: https://www.walls...

ORLANDO, Fla., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Today’s featured company Hoth Therapeutics, Inc. (NASDAQ: HOTH) makes its claim in the marketplace of Life Science ideas with an array of skin-related products that span a large portion of the dermalogical spectrum. As a relatively ...

CEO Interviews with: HEXO, HOTH, MDCL, NEXCF News & VIDEO from Investor Conferences: NEXCF, MDCL NEW YORK, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has recently published published CEO Interviews, and conference presen...

NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has recently published published CEO Interviews, video presentations, and news updates from the company’s presenting at last month’s NEXT SUPER STOCK Live! inves...

NEW YORK, NY / ACCESSWIRE / September 16, 2019 / Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies has initiated coverage of Hoth Therapeutics, Inc. (NASDAQ: HOTH ). The in-depth 24-page initiation report includ...

NEW YORK , Sept. 6, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chron...

NEW YORK , Sept. 4, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from dermatological indications ranging from atopic dermatitis to chronic wound disorders, today issued a letter to s...

Hoth Therapeutics (NASDAQ: HOTH ) inks an agreement with Greenville, SC-based Zylö Therapeutics to develop an new topical therapy for cutaneous lupus erythematosus  (CLE), an autoimmune disorder affecting the skin. More news on: Hoth Therapeutics, Inc., Healthcare stocks new...